|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2008-06-30 Option Award |
2008-08-27 4:45 pm | N/A 2018-06-30 |
REXAHN PHARMACEUTICALS, INC. | RNN | McIntosh David M (Director) | 20,000 | $3.24 | 20,000 (Direct) | View |
| 2007-06-11 Option Award |
2007-06-13 4:15 pm | 2008-06-11 2017-06-11 |
REXAHN PHARMACEUTICALS, INC. | RXHN | McIntosh David M (Director) | 20,000 | $1.4 | 20,000 (Direct) |
View |
| 2005-12-08 Option Sale |
2006-05-03 9:06 pm |
N/A 2014-04-20 | REXAHN PHARMACEUTICALS, INC. | RXHN | McIntosh David M (Director) | 125,000 | $0.24 | 0 (Direct) |
View |
| 2005-12-08 Option Award |
2006-05-03 9:06 pm | N/A 2014-04-20 |
REXAHN PHARMACEUTICALS, INC. | RXHN | McIntosh David M (Director) | 125,000 | $0.8 | 125,000 (Direct) |
View |
| 2005-09-12 Option Award | 2006-05-03 9:06 pm |
2006-09-12 2015-09-12 | REXAHN PHARMACEUTICALS, INC. | RXHN | McIntosh David M (Director) | 20,000 | $3 | 20,000 (Direct) | View |
| 2006-05-01 Option Award | 2006-05-03 9:06 pm | 2007-05-01 2016-05-01 | REXAHN PHARMACEUTICALS, INC. | RXHN | McIntosh David M (Director) | 20,000 | $1.2 | 20,000 (Direct) |
View |
| 2005-05-13 Option Award |
2005-05-17 9:25 pm | N/A 2014-04-20 |
REXAHN PHARMACEUTICALS, INC. | RXHN | McIntosh David M (Director) | 125,000 | $0.24 | 125,000 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Mon, 01 Dec 2008 22:40:19 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |